Adipose tissue is required for normal metabolic function, but abnormal proliferation of adipocytes results in obesity. Although retinoic acid (RA) promotes differentiation of a variety of cell types, RA inhibits adipose conversion of 3T3-L1 preadipocytes. In contrast, activators of peroxisome proliferator activated receptors (PFARs), which are highly related to nuclear retinoid receptors, induce adipose conversion. The goal of this research is to understand the molecular basis of nuclear hormone receptor actions and interactions in this system. The first specific aim of this proposal is to determine the role of specific RAR subtypes and isoforms in adipocyte differentiation. 3T3-L1 preadipocytes express multiple retinoic acid receptors (RARs). RARgamma1 is down-regulated early and correlates with the effects of RA. Moreover, constitutive expression of RARgamma1 prevents adipocyte differentiation. Thus, RARgamma1 has a particularly important role in adipocyte differentiation and its mechanism of action will be determined. The second specific aim is to determine the role of specific retinoid X receptor (RXR) subtypes in adipocyte differentiation. RXRs are retinoid receptors which heterodimerize with RARs. RXRalpha is induced shortly after exposure to differentiating conditions, and preliminary data suggest that its expression causes preadipocytes to differentiate. The mechanism by which RXRalpha exerts these effects will be determined. RXR also heterodimerizes with PPAR. The third specific aim is to determine the role of specific forms of PPAR in adipocyte differentiation. Three PPAR subtypes are induced during adipocyte differentiation, but PPARgamma is most interesting because its expression is fat-specific and induced early in the course of adipogenesis. Each of the specific aims will be accomplished by creating 3T3-L1 cell lines which constitutively express different receptor subtypes, then studying the differentiation of these cells in the presence or absence of RA or peroxisome proliferators. Inducible promoters and antisense approaches will also be used to generate cell lines and analyze the effects of specific receptors. In addition, the mechanism of subtype- specific effects will be studied using deletion mutants and chimeric receptors. The fourth specific aim is to understand the hierarchical roles of RAR, RXR, and PPAR during adipocyte differentiation. It is hypothesized that the changes in expression of the nuclear hormone receptors reflect temporal and causal hierarchies of gene expression and regulation. To test this, the phenotypic dominance of cell lines which stable co-express two receptors involved in adipogenesis (e.g., RARgamma1 and RXRalpha will be determined. Together, the proposed studies will provide insight into the role of nuclear receptors and ligands in fat cell growth and differentiation. This knowledge may lead to rational new approaches to the prevention and treatment of human obesity, which is an endemic and costly cause of morbidity and mortality in the U. S.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK049780-03
Application #
2444147
Study Section
Endocrinology Study Section (END)
Program Officer
Haft, Carol R
Project Start
1995-07-01
Project End
1999-06-30
Budget Start
1997-07-01
Budget End
1998-06-30
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Zhang, Yinxin; Dallner, Olof Stefan; Nakadai, Tomoyoshi et al. (2018) A noncanonical PPAR?/RXR?-binding sequence regulates leptin expression in response to changes in adipose tissue mass. Proc Natl Acad Sci U S A 115:E6039-E6047
Hill, David A; Lim, Hee-Woong; Kim, Yong Hoon et al. (2018) Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue. Proc Natl Acad Sci U S A 115:E5096-E5105
Lazar, Mitchell A (2018) Reversing the curse on PPAR?. J Clin Invest 128:2202-2204
Plikus, Maksim V; Guerrero-Juarez, Christian F; Ito, Mayumi et al. (2017) Regeneration of fat cells from myofibroblasts during wound healing. Science 355:748-752
Soccio, Raymond E; Li, Zhenghui; Chen, Eric R et al. (2017) Targeting PPAR? in the epigenome rescues genetic metabolic defects in mice. J Clin Invest 127:1451-1462
Lazar, Mitchell A (2017) Maturing of the nuclear receptor family. J Clin Invest 127:1123-1125
Jager, Jennifer; Wang, Fenfen; Fang, Bin et al. (2016) The Nuclear Receptor Rev-erb? Regulates Adipose Tissue-specific FGF21 Signaling. J Biol Chem 291:10867-75
Ferrannini, Giulia; Namwanje, Maria; Fang, Bin et al. (2016) Genetic backgrounds determine brown remodeling of white fat in rodents. Mol Metab 5:948-58
Soccio, Raymond E; Chen, Eric R; Rajapurkar, Satyajit R et al. (2015) Genetic Variation Determines PPAR? Function and Anti-diabetic Drug Response In Vivo. Cell 162:33-44
Cohen, Daniel M; Won, Kyoung-Jae; Nguyen, Nha et al. (2015) ATF4 licenses C/EBP? activity in human mesenchymal stem cells primed for adipogenesis. Elife 4:e06821

Showing the most recent 10 out of 63 publications